HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential survival benefit of universal HAART access in Brazil: a nation-wide comparison of injecting drug users versus men who have sex with men.

AbstractOBJECTIVE:
Brazil accounts for approximately 70% of injection drug users (IDUs) receiving highly active antiretroviral therapy (HAART) in low-income/middle-income countries. We evaluated the impact of HAART availability/access on AIDS-related mortality among IDUs versus men who have sex with men (MSM).
DESIGN:
Nation-wide analysis on Brazilian IDU and MSM diagnosed with AIDS in 2000-2006.
METHODS:
Four national information systems were linked, and Cox regression was used to assess impact of HAART availability/access on differential AIDS-related mortality.
RESULTS:
Among 28,426 patients, 6777 died during 87,792 person-years of follow-up. Compared with MSM, IDU were significantly less likely to be receiving HAART, to have ever had determinations for CD4 or viral load. After controlling for confounders, IDU had a significantly higher risk of death (adjusted hazard ratio: 1.94; 95% confidence interval: 1.84 to 2.05). Among the subset that had at least 1 CD4 and viral load determination, higher risk of death among IDU persisted (hazard ratio: 1.82; 95% confidence interval: 1.58 to 2.11). Nonwhite ethnicity significantly increased this risk, whereas prompt HAART uptake after AIDS diagnosis reduced the risk of death. After controlling for spatially correlated survival data, AIDS-related mortality remained higher in IDU than in MSM.
CONCLUSIONS:
Despite free/universal HAART access, differential AIDS-related mortality exists in Brazil. Efforts are needed to identify and eliminate these health disparities.
AuthorsMonica Malta, Francisco I Bastos, Cosme M F P da Silva, Gerson Fernando Mendes Pereira, Francisca F A Lucena, Maria G P Fonseca, Steffanie A Strathdee
JournalJournal of acquired immune deficiency syndromes (1999) (J Acquir Immune Defic Syndr) Vol. 52 Issue 5 Pg. 629-35 (Dec 2009) ISSN: 1944-7884 [Electronic] United States
PMID19675464 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Topics
  • Acquired Immunodeficiency Syndrome (drug therapy, mortality)
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antiretroviral Therapy, Highly Active
  • Brazil (epidemiology)
  • Databases, Factual
  • Developing Countries
  • HIV-1
  • Health Services Accessibility
  • Healthcare Disparities
  • Homosexuality, Male
  • Humans
  • Male
  • Middle Aged
  • Risk Factors
  • Substance Abuse, Intravenous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: